Uppsala Reports editor
@UMCGlobalSafety
Jean Marie Vianney Habarugira and Albert Figueras are all for using pharmacovigilance databases for AMR surveillance. Hear them out on the latest episode of Drug Safety Matters.
Managing antimicrobial resistance (AMR) will require innovative solutions from many different disciplines. Could pharmacovigilance be one of them?
In the latest episode of Drug Safety Matters, Jean Marie Vianney Habarugira and Albert Figueras, who have been investigating how drug safety tools could help track AMR, tell podcast host Federica Santoro why they think it’s time the two communities joined forces for good.
Subscribe by visiting the Drug Safety Matters website or listen in right here:
While underreporting remains a persistent global challenge, innovative approaches are showing promise in different regions
18 February 2026
An Australian research team is using artificial intelligence to improve the safe dosing of unfractionated heparin, a high-risk drug linked to serious side effects.
30 March 2026
Complementary medicines are widely used and often perceived as safe, yet high doses, product stacking, and unclear labelling can quietly increase the risk of harm.
07 April 2026